Results: At the sensor-level, we identified distinct temporal profiles of hierarchical PEs (peak effects: aPE at 112ms, vPE at 276ms). In source space, three sources showed significant effects for both PEs: anterior temporoparietal junction (TPJ), dorsal middle cingulate cortex (MCC) and supplementary motor cortex (SMA). To identify the connections that convey PEs, we compared two DCM families that allowed input to different nodes of the network, and different modulatory effects of PE magnitude. The family with input entering the SMA and propagating via MCC to TPJ explained aPE-evoked activity best, whereas the family with input into the TPJ and propagating in the opposite direction best described the effects of vPE-evoked activity. Bayesian model selection identified the winning model for aPE effects; this model proposed PE magnitude modulations of input gain and effective connectivity from TPJ to MCC, and MCC to SMA. Conversely, a model with connectivity modulation from MCC to TPJ best described the effects of vPE. Second, we investigated the impact of dopaminergic perturbations of the network by comparing DCM parameters of the winning models across pharmacological groups. Post hoc t-tests revealed that DA impacted on aPE-induced perturbations only, which is in line with previous findings that aPEs are represented in dopaminergic regions while vPEs are likely encoded by activity in cholinergic regions. Specifically, DA modulated TPJ-MCC and SMA-MCC connectivity. Discussion: Model-based analysis of EEG data in a social learning task detects DA effects on connectivity, even when behavior (accuracy, reaction time) was not affected by the drugs. Currently, we are extending our computational approach to first-episode schizophrenia patients, where we hope to use parameters from neuronal and behavioral models to predict individual treatment response. 
F238. COMPETENCE-PERFORMANCE

Toho University School of Medicine
Background: Social functioning deficits are of critical importance in patients with schizophrenia, because they affect the long-term outcomes and quality of life (QOL) of the patients. Two aspects of social functioning, namely, competence (ability to perform skilled activities, that is, what one can do) and performance (actual performance of skilled activities, that is, what one actually does) are considered to have a significant influence on how well the patients can live independently in the community. Although the two aspects are usually thought to go hand in hand, discrepancy between the two is often observed in patients with schizophrenia in clinical practice. Some patients are not able to function in the community to the best of their ability; some patients appear to get along everyday living better than they would be expected to. The aim of the present study was to identify factors influencing the occurrence of such discrepancy of social functioning in patients with schizophrenia. Methods: A total of 205 stable outpatients with schizophrenia aged 40 years old or under were recruited at the Toho University Omori Medical Center, Tokyo. Of the 205 patients, 100 were male (48.8%) and 105 (51.2%) were female. The mean age of the participants was 29.3 years and the mean estimated premorbid IQ was 100.8. The mean age at disease onset was 22.0 years old, and the mean duration of illness at the start of the study was 6.7 years. The social functioning, psychiatric symptoms, social anxiety, cognitive function, and QOL of the participants were assessed. The patients were divided into 4 groups by the cutoff points for competence and performance calculated using a comprehensive dataset of the Social Functioning Scale (SFS) obtained from multiple facilities. Results: The subjects were divided according to their level of competence and performance as follows: good competence and good performance (CP) group, 108 (52.7%) patients; good competence but poor performance (Cp) group, 40 (19.5%) patients; poor competence but good performance (cP) group, 13 (6.3%) patients; poor competence and poor performance (cp) group, 44 (21.5%) patients. Among the 4 groups, the objects of particular interest in this study were the differences between CP and Cp groups and between the cP and cp groups. One-way ANOVA revealed significant differences among the groups in the scores on the Positive and Negative Syndrome Scale (PANSS), Liebowitz Social Anxiety Scale (LSAS), Global Assessment of Functioning Scale (GAF), World Health OrganizationQuality of Life 26 (WHOQOL26), and Social Functioning Scale (SFS). Post-hoc comparisons revealed that the PANSS negative symptoms and general psychopathology scores, GAF score, WHOQOL26 score, and SFS total score were significantly worse in the Cp group than in the CP group, and that the LSAS score, GAF score, WHOQOL26 score, and SFS total score were significantly better in the cP group than in the cp group. Discussion: In patients who are capable of living well in the community but do not perform well, negative symptoms may be involved in this discrepancy of social functioning. Patients who are able to maintain themselves well despite their poor social competence appear to have milder social anxiety symptoms as compared to patients who are neither competent nor capable of performing well in terms of social functioning in the community. Suitable and personalized approaches based on the patients' profile of dysfunction would seem to be indispensable for the recovery of such patients.
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Background: Optimizing psychosocial functioning and overall well-being by reducing the severity of negative symptoms are important outcomes for individuals with schizophrenia. Movement-based therapeutic approaches are uniquely capable of addressing the non-verbal nature of negative symptoms. Dance/Movement Therapy (DMT), a promising treatment for mental health conditions such as schizophrenia, has been found to reduce the occurrence and severity of negative symptoms and to have a positive impact on the psychosocial functioning. Although preliminary findings suggest DMT as a treatment intervention, limited research and inconclusive findings preclude generalizations and more research is needed. We aimed to examine the treatment effects of a 10-week (20 sessions) group DMT treatment program. Methods: We employed a mixed methods intervention design with explanatory intent, in which a randomized controlled trial is followed by semistructured exit interviews. Thirty-one severely ill individuals diagnosed with schizophrenia participated in the RCT that used a two-arm parallel group design to assess and show the difference between patients receiving standard care (SC) and patients receiving standard care plus DMT on measures of negative symptoms (as primary outcome; PANSS, BNSS) and psychosocial functioning (as secondary outcomes; WHO-DAS 2.0, SDS). Quantitative measures were taken pre and post-intervention. Participants who participated in a minimum of 50% of DMT sessions (n=15) were invited to an exit interview. This criterion was also used to analyze quantitative data, leaving n=28 for quantitative analysis.
Results: All participants in both groups (n=31) completed the study. Because of such a small sample size (n=28) and a pilot nature of the study we were restricted to use descriptive statistics. The quantitative data suggest that DMT and SC were not equally effective in enhancing primary outcomes. Analysis of the PANSS mean score changes showed a slight increase in the negative symptom in the DMT from 28.33 ± 4.76 to 29.00 ± 4.10, and slight decrease in the SC from 28.92 ± 5.72 to 27.08 ± 5.64. BNSS scores indicate that both groups improved. SC participants reported grater reduction on BNSS overal score from 53.31 ± 11.48 to 47.77 ± 8.10 in comparison to DMT from 53.07 ± 7.27 to 51.93 ± 6.18. However, DMT participants reported reduction of symptoms in distress, antisocial activity, avolition and verbal expression. Analysis of WHO-DAS suggests that DMT was effective in reduction of disability severity compared to SC. DMT participants reported grater improvement in cognition, mobility, self-care, and getting along. Both groups reported reduction of the impact of difficulties on daily functioning on SDS, however DMT participants reported a greater reduction in days during which they were completely unable to perform or had to limit their usual activities or work due to symptoms. In the SC, the results suggest a reduction in the number of days lost and days of lower productivity. Qualitative findings identified participants' experiences and the most important themes related to benefits of the DMT intervention: enhanced activation, motivation, socialization, and self-awareness. Discussion: Results of this study contribute to knowledge about bodybased interventions for schizophrenia and indicate that DMT had an effect on participants psychosocial functioning and coping with negative symptoms. Integration of quantitative and qualitative data provides a wider perspective by gaining a better understanding of the treatment outcomes and explaining inconclusive results. Findings of this study set the stage for larger fully powered research, examining intervention methods and procedures, as well as treatment effects, more thoroughly. Background: In order to extract the most powerful predictive models from data collected within the PRONIA study, diverse information sources must be combined. PRONIA aims to combine information from a range of study sites across Europe as well as from a diverse range of information sources. For each subject, neurocognitive, neuroimaging and clinically observed data has been collected that is intended to provide the basis for the development of predictive models for use in individualised diagnosis and prediction. However, as yet it is unclear as to which elements (or combination) of the measured data provide optimal predictive capacity and which features will generalize best. Methods: In order to combine data from a diverse range of sources a number of approaches may be considered. While it is initially attractive to concatenate the features gathered from each modality, this approach is problematic in two ways. Not only do the appropriate pre-processing steps differ between modalities, but the high dimensionality of imaging data (in comparison to neurocognitive measures) may alter the way each modality contributes to the decision function during learning. Instead, we investigate more simplistic learning approaches in an initial step that produces a single outcome for each modality considered. In a second step these outcomes are combined to generate a final estimate of the target class. In this investigation neurocognitive and neuroimaging data, collected as part of the PRONIA study, were considered as features for prediction of clinically observed global function, measured at the same time-point. Each neurocognitive test, applied as part of the PRONIA battery, was considered as an independent modality, as were each of a range of MRI-based neuroimaging measures (from structural, functional and diffusion imaging). Support Vector Classification (SVC) was conducted for each modality, with the target class defined as a score of 65 or less on the Global Assessment of Function. Both linear classification and the use of radial basis functions were explored within the initial modality-independent learning phase as well as during modality fusion as part of the second learning phase. Repeated, nested, cross-validation was employed in both stages in order ensure robust estimates of generalisation. Results: Because each modality is reduced to a single measure in the first stage, each can contribute on an equal basis to the predictive outcome in the second while allowing inter-modality interaction. While SVC models do not naturally provide probabilistic outcomes, the distance of each point to the separating hyperplane can be scaled to represent the relative class probabilities. Predictions obtained at the first stage not only provide for the second phase of learning, but also provide a means to assess each modality for predictive accuracy. Correlations between the predictions from each mode provide information as to which combination of data may contribute constructively to the final outcome while learning approaches within the second phase can also be used to identify the most useful predictors. Discussion: The two-stage learning framework provides a useful approach to learning that allows assessment of each separate data stream as well as the fused-prediction outcome. The contribution of each data stream to the final prediction may be explored while interactions between data streams can also be contextualised. However, more subtle interactions between data, particularly at the initial input stage, may be difficult to observe and so the extension of this approach to more structured data-fusion and is considered.
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